Kangyuan pharmaceutical's revenue and net profit in the first half of the year decreased by 3162% and 4046% respectively - 彩票平台

Kangyuan pharmaceutical's revenue and net profit in the first half of the year decreased by 3162% and 4046% respectively

Today, Kangyuan Pharmaceutical (zoqing 600557, diagnosis stock) (SH: 600557) released the semi annual performance express of 2020, during the notice period, Beijing lottery fast 3, achieved a total sales of 1.547 billion yuan, Beijing lottery fast 3, a year-on-year decline of 31.62%; the net income attributable to shareholders of listed companies was 144 million yuan, a year-on-year decrease of 40.46%.

[0} according to Kangyuan pharmaceutical, during the notice period, due to the impact of the new type of coronavirus pulmonary fever epidemic prevention measures, the general outpatient department of the hospital failed to receive regular consultation, especially the outpatient number of Pediatrics in medical institutions was relatively negative, which led to the company's trading performance being relatively negative since its listing in 2002.